Department of Biological Sciences, University of Illinois at Chicago , Chicago, IL 60607 , USA.
Biol Open. 2013 May 23;2(7):686-94. doi: 10.1242/bio.20134747. Print 2013 Jul 15.
Primary cilia protrude from the cell surface of many cell types in the human body and function as cellular antennae via ciliary membrane localized receptors. Neurons and glial cells in the brain possess primary cilia, and the malfunction of primary cilia may contribute to neurological deficits present in many cilia-associated disorders. Several rhodopsin family G-protein coupled receptors (GPCRs) are specifically localized to a subset of neuronal primary cilia. However, whether other family GPCRs target to neuronal cilia and whether glial primary cilia harbor any GPCRs are not known. We conducted a screening of GPCRs to determine their ability to target to primary cilia, and identified a secretin family member, Vasoactive Intestinal Receptor 2 (VPAC2), as a novel ciliary GPCR. Here, we show that endogenous VPAC2 targets to primary cilia in various brain regions, including the suprachiasmatic nuclei and the thalamus. Surprisingly, VPAC2 not only localizes to neuronal cilia but also to glial cilia. In addition, we show that VPAC2's C-terminus is both necessary and sufficient for its ciliary targeting and we define a novel ciliary targeting signal: the tetrapeptide RDYR motif in the C-terminus of VPAC2. Furthermore, we demonstrate that VPAC2 ciliary targeting is dependent on Tubby, the BBSome (a complex of Bardet-Biedl syndrome proteins) and the BBSome targeting factor, Arl6.
原发性纤毛从人体许多细胞类型的细胞表面伸出,并通过纤毛膜定位受体作为细胞天线发挥作用。大脑中的神经元和神经胶质细胞都拥有原发性纤毛,而原发性纤毛的功能障碍可能导致许多与纤毛相关的疾病中存在神经缺陷。一些视蛋白家族 G 蛋白偶联受体 (GPCR) 特异性定位于神经元原发性纤毛的一部分。然而,其他家族的 GPCR 是否靶向神经元纤毛,以及神经胶质原发性纤毛是否存在任何 GPCR 尚不清楚。我们进行了 GPCR 的筛选,以确定它们靶向原发性纤毛的能力,并鉴定出一种分泌素家族成员,血管活性肠肽受体 2(VPAC2),作为一种新型的纤毛 GPCR。在这里,我们表明内源性 VPAC2 靶向各种脑区的原发性纤毛,包括视交叉上核和丘脑。令人惊讶的是,VPAC2 不仅定位于神经元纤毛,也定位于神经胶质纤毛。此外,我们表明 VPAC2 的 C 端对于其纤毛靶向是必需且充分的,并且我们定义了一个新的纤毛靶向信号:VPAC2 的 C 端中的四肽 RDYR 基序。此外,我们证明 VPAC2 的纤毛靶向依赖于 Tubby、BBSome(一种 Bardet-Biedl 综合征蛋白复合物)和 BBSome 靶向因子 Arl6。